
|Videos|January 4, 2018
Dr. Carvajal Discusses the Biology of Extracutaneous Melanoma
Author(s)Richard Carvajal, MD
Richard Carvajal, MD, director of Experimental Therapeutics and director of the Melanoma Service at Columbia University Medical Center, discusses the biology and distinctions of extracutaneous melanoma.
Advertisement
Richard Carvajal, MD, director of Experimental Therapeutics and director of the Melanoma Service at Columbia University Medical Center, discusses the biology and distinctions of extracutaneous melanoma.
Extracutaneous melanoma is a very distinct disease from a biological and clinical standpoint, according to Carvajal. Extracutaneous melanoma needs to be thought of as a different disease than cutaneous melanoma, Carvajal adds, since they do not respond to treatments the same way.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
5



































